• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

The natural history of infant spinal muscular atrophy in China: a study of 237 patients.

作者信息

Ge Xiushan, Bai Jinli, Lu Yanyu, Qu Yujin, Song Fang

机构信息

Department of Medical Genetics, Capital Institute of Pediatrics, Beijing, China.

出版信息

J Child Neurol. 2012 Apr;27(4):471-7. doi: 10.1177/0883073811420152. Epub 2011 Sep 27.

DOI:10.1177/0883073811420152
PMID:21954429
Abstract

The authors retrospectively studied the natural history of 237 patients with infantile spinal muscular atrophy in China. The onset ages (mean ± SD) for types I to III were 3.1 ± 2.7, 8.7 ± 3.8, and 21.1 ± 11.7 months, respectively. The survival probabilities for type I patients at 1, 2, and 5 years were 44.9%, 38.1%, and 29.3%, respectively, and for type II patients, the probabilities were 100%, 100%, and 97%, respectively. All type III patients were alive. Type I patients with onset age after 2 months had significantly increased survival than those with onset before 2 months (P < .05). It should be noticed that survival probability at 2 years in type I patients in our study was close to that in other Asian samples of spinal muscular atrophy, but slightly better than that among whites. Patients accepted minimal proactive interventions other than antibiotics for pulmonary infection, so our study provides reliable baseline data of natural history of spinal muscular atrophy in China.

摘要

相似文献

1
The natural history of infant spinal muscular atrophy in China: a study of 237 patients.
J Child Neurol. 2012 Apr;27(4):471-7. doi: 10.1177/0883073811420152. Epub 2011 Sep 27.
2
Spinal muscular atrophy: survival pattern and functional status.脊髓性肌萎缩症:生存模式与功能状态
Pediatrics. 2004 Nov;114(5):e548-53. doi: 10.1542/peds.2004-0668. Epub 2004 Oct 18.
3
Pathophysiological insights derived by natural history and motor function of spinal muscular atrophy.脊髓性肌萎缩症自然病史和运动功能得出的病理生理学见解。
J Pediatr. 2013 Jan;162(1):155-9. doi: 10.1016/j.jpeds.2012.05.067. Epub 2012 Jul 17.
4
Autosomal recessive proximal spinal muscular atrophy in 101 sibs out of 48 families: clinical picture, influence of gender, and genetic implications.48个家庭中101名同胞患常染色体隐性遗传性近端脊髓性肌萎缩症:临床表现、性别影响及遗传学意义
Am J Med Genet. 1994 May 15;51(1):70-6. doi: 10.1002/ajmg.1320510115.
5
The changing natural history of spinal muscular atrophy type 1.1型脊髓性肌萎缩症不断变化的自然病史。
Neurology. 2007 Nov 13;69(20):1931-6. doi: 10.1212/01.wnl.0000290830.40544.b9.
6
[Clinical, electrophysiological and molecular study of 26 chilean patients with spinal muscular atrophy].26例智利脊髓性肌萎缩症患者的临床、电生理及分子研究
Rev Med Chil. 2011 Feb;139(2):197-204. Epub 2011 Jul 11.
7
A phase 1 trial of riluzole in spinal muscular atrophy.
Arch Neurol. 2003 Nov;60(11):1601-3. doi: 10.1001/archneur.60.11.1601.
8
Natural history of spinal and bulbar muscular atrophy (SBMA): a study of 223 Japanese patients.脊髓延髓肌萎缩症(SBMA)的自然病史:对223例日本患者的研究。
Brain. 2006 Jun;129(Pt 6):1446-55. doi: 10.1093/brain/awl096. Epub 2006 Apr 18.
9
Natural history in proximal spinal muscular atrophy. Clinical analysis of 445 patients and suggestions for a modification of existing classifications.近端脊髓性肌萎缩症的自然病史。445例患者的临床分析及对现有分类进行修订的建议。
Arch Neurol. 1995 May;52(5):518-23. doi: 10.1001/archneur.1995.00540290108025.
10
Natural history of spinal-bulbar muscular atrophy.脊髓延髓肌肉萎缩症的自然病史。
Neurology. 2008 May 20;70(21):1967-71. doi: 10.1212/01.wnl.0000312510.49768.eb.

引用本文的文献

1
Real-world analysis of the efficacy and safety of nusinersen in pediatric patients with spinal muscular atrophy.诺西那生钠治疗小儿脊髓性肌萎缩症疗效与安全性的真实世界分析
Orphanet J Rare Dis. 2025 Feb 26;20(1):87. doi: 10.1186/s13023-025-03603-9.
2
Association among biomarkers, phenotypes, and motor milestones in Chinese patients with 5q spinal muscular atrophy types 1-3.中国1-3型5q脊髓性肌萎缩症患者生物标志物、表型与运动里程碑之间的关联
Front Neurol. 2024 Sep 2;15:1382410. doi: 10.3389/fneur.2024.1382410. eCollection 2024.
3
Survival analysis and life expectancy of pediatric patients with spinal muscular atrophy in Thailand.
泰国脊髓性肌萎缩症儿科患者的生存分析与预期寿命
Heliyon. 2024 Jun 8;10(11):e32732. doi: 10.1016/j.heliyon.2024.e32732. eCollection 2024 Jun 15.
4
A Post-Marketing Surveillance Study of Nusinersen for Spinal Muscular Atrophy in Routine Medical Practice in China: Interim Results.在中国常规医疗实践中进行的依洛硫酸酯酶β治疗脊髓性肌萎缩症的上市后监测研究:中期结果。
Adv Ther. 2024 Jul;41(7):2743-2756. doi: 10.1007/s12325-024-02852-7. Epub 2024 May 9.
5
Systematic Literature Review of the Natural History of Spinal Muscular Atrophy: Motor Function, Scoliosis, and Contractures.脊髓性肌萎缩症自然史的系统文献回顾:运动功能、脊柱侧凸和挛缩。
Neurology. 2023 Nov 21;101(21):e2103-e2113. doi: 10.1212/WNL.0000000000207878. Epub 2023 Oct 9.
6
Case Report: A case of spinal muscular atrophy with extensively drug-resistant pneumonia treated with nebulization combined with intravenous polymyxin B: experience and a literature review.病例报告:一例广泛耐药性肺炎的脊髓性肌萎缩症患者采用雾化吸入联合静脉注射多黏菌素 B 治疗的病例:经验与文献回顾。
Front Cell Infect Microbiol. 2023 Jun 21;13:1163341. doi: 10.3389/fcimb.2023.1163341. eCollection 2023.
7
Comprehensive profile and natural history of pediatric patients with spinal muscular atrophy: A large retrospective study from China.中国小儿脊髓性肌萎缩症患者的综合概况与自然病史:一项大型回顾性研究
Front Neurol. 2022 Dec 20;13:1038012. doi: 10.3389/fneur.2022.1038012. eCollection 2022.
8
Natural history of spinal muscular atrophy in children: an analysis of 117 cases.儿童脊髓性肌萎缩症自然史:117 例分析。
Zhongguo Dang Dai Er Ke Za Zhi. 2021 Oct 15;23(10):1038-1043. doi: 10.7499/j.issn.1008-8830.2106025.
9
Prognostic Factors and Treatment-Effect Modifiers in Spinal Muscular Atrophy.脊髓性肌萎缩症的预后因素和治疗效果调节剂。
Clin Pharmacol Ther. 2021 Dec;110(6):1435-1454. doi: 10.1002/cpt.2247. Epub 2021 Jun 5.
10
Natural history of lung function in spinal muscular atrophy.脊髓性肌萎缩症患者肺功能自然史。
Orphanet J Rare Dis. 2020 Apr 10;15(1):88. doi: 10.1186/s13023-020-01367-y.